Showing results (171-180 of 305) with videos related to
Sort By:
Pageof 31
Proceedings of the National Academy of Sciences of the United States of America|January 26, 2011
Human thrombopoietin knockin mice efficiently support human hematopoiesis in vivoAnthony Rongvaux, Tim Willinger, Hitoshi Takizawa, et al.Blood Advances|December 5, 2024
Advantages of a genomic DNA-based next-generation sequencing assay for detection of mutant NPM1 measurable residual disease in AMLChristian M Vonk, Tim Grob, Melissa Rijken, et al.Investigational New Drugs|July 12, 2019
Dirty deeds done dirt cheap: sensitization of prostate cancer cells to abiraterone treatment using hydroxylated polychlorinated biphenylsGabriel Daragan, Jenny Hoffmann, Theresa Vasko, et al.Archives of Toxicology|March 19, 2021
Longitudinal changes in telomere length in PCB-exposed individuals: interaction with CMV infectionFabian Beier, Andre Esser, Lucia Vankann, et al.EMBO Molecular Medicine|November 9, 2013
Fas (CD95) expression in myeloid cells promotes obesity‐induced muscle insulin resistanceStephan Wueest, Rouven Mueller, Matthias Blüher, et al.Molecular Therapy Oncolytics|August 16, 2023
Anti-CD117 CAR T cells incorporating a safety switch eradicate human acute myeloid leukemia and hematopoietic stem cellsChiara F Magnani, Renier Myburgh, Silvan Brunn, et al.The Journal of Experimental Medicine|October 28, 2021
Chronic viral infections persistently alter marrow stroma and impair hematopoietic stem cell fitnessStephan Isringhausen, YeVin Mun, Larisa Kovtonyuk, et al.Nature Cancer|April 20, 2023
Ex vivo drug response heterogeneity reveals personalized therapeutic strategies for patients with multiple myelomaKlara Kropivsek, Paul Kachel, Sandra Goetze, et al.Journal for Immunotherapy of Cancer|August 14, 2024
An IL-7 fusion protein targeting EDA fibronectin upregulates TCF1 on CD8+ T-cells, preferentially accumulates to neoplastic lesions, and boosts PD-1 blockadeCesare Di Nitto, Domenico Ravazza, Ettore Gilardoni, et al.International Journal of Cancer|August 23, 2024
Tripokin: A multi-specific immunocytokine for cancer immunotherapyEleonora Prodi, Riccardo Corbellari, Lorenzo Ghezzi, et al.Pageof 31